Skip to content

Treatment of Head Lice Infestation Using Novel Ultrasonic Comb

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02854878
Enrollment
23
Registered
2016-08-04
Start date
2016-11-28
Completion date
2018-07-26
Last updated
2019-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediculus Capitis

Brief summary

A pilot study to evaluate safety and efficacy of the Lucy combined with LucyGel in killing head lice and their eggs. 23 participants will be enrolled in this study. The first 12 will be combed with model A and the remaining 11 will be combed with model B

Interventions

DEVICEThe Lucy ultrasonic comb models A and B combined with the LucyGel

Sponsors

ParaSonic Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Males and Females * Age 6 years and older at the time of enrollment * Must have an active head lice infestation of at least 10live head lice (found within 5 minutes of mechanic search). * Hair must be at least 3 cm long. * Written informed consent - by patient (if over 18 years of age), or by a parent (if patient is under 18 years of age). * For females of childbearing potential, a statement declaring that she is not currently pregnant.

Exclusion criteria

* Used any chemical head lice treatment in the 7 days preceding the trial treatment * Used antibiotics in the week preceding treatment * Open wounds in the treatment area * Skin irritation in the treatment area * Individuals with skin/scalp condition at the treatment site which, in the opinion of the investigator, will interfere with treatment or evaluation * Known allergies to any of the gel's components * Participant that is already enrolled in another study * Participant who can't be combed with fine Comb dense ASSY2000

Design outcomes

Primary

MeasureTime frameDescription
Adverse events of the device and treatmentup to three daysmeasured by AE

Secondary

MeasureTime frame
Mortality of up to 70% of the mature head lice 3 hours post treatment3 hours post treatment
Mortality of up to 50% of the head lice eggs 14 days post treatment.14 days post treatment

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026